{"url_path":"/sec/cnmd/8-k/2026-06-01/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/816956/0002077096-26-000190-index.html","accession_number":"0002077096-26-000190","cik":"0000816956","ticker":"CNMD","issuer_name":"CONMED Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/816956/0002077096-26-000190-index.html","primary_entity_key":"0000816956","primary_entity_name":"CONMED Corp"},"word_count":570,"has_tables":true,"body_markdown":"** **\n\n \n\n****\n\n** **\n\n \n\n** **\n\n**Item 1.01**\n**Entry into a Material Definitive Agreement.**\n\n** **\n\nOn May 27, 2026, CONMED Corporation, a Delaware\ncorporation (“CONMED”) entered into the First Omnibus Amendment and Increased Facility Activation Notice (the “First\nAmendment”), among CONMED and its subsidiary Linvatec Nederland B.V., a Netherlands private limited company (*besloten vennootschap*),\nas borrowers; certain of CONMED’s other subsidiaries, as guarantors; the several banks and other financial institutions party thereto,\nas lenders; and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”). The First Amendment\namends (i) the Eighth Amended and Restated Credit Agreement, dated as of June 10, 2025 (the “Base Credit Agreement”\nand, as amended by the First Amendment, the “Credit Agreement” ), among CONMED, the Foreign Subsidiary Borrowers (as\ndefined therein) from time to time parties thereto, the several banks and other financial institutions or entities from time to time parties\nthereto, and the Administrative Agent and (ii) the Amended and Restated Guarantee and Collateral Agreement, dated as of June 10, 2025\n(the “Base Guarantee and Collateral Agreement” and, as amended by the First Amendment, the “Guarantee and\nCollateral Agreement”) by CONMED and the other subsidiaries party thereto, in favor of the Administrative Agent. The Base Credit\nAgreement and the Base Guarantee and Collateral Agreement were filed as Exhibits 10.1 and 10.2, respectively, to CONMED’s Current\nReport on Form 8-K filed with the Securities and Exchange Commission on June 16, 2025.\n\n \n\nCONMED entered into the First Amendment to, among\nother things, obtain commitments for incremental senior secured delayed draw term “a” loans available in U.S. dollars to CONMED\nin an aggregate principal amount equal to $450 million (the “Term A-2 Loan Facility”), which is available to be\nborrowed in a single drawing on or prior to June 14, 2026. The Term A-2 Loan Facility matures on June 10, 2030, the same maturity\ndate as the existing revolving and term loan facilities under the Base Credit Agreement. The proceeds of the Term A-2 Loan Facility will\nbe available to repurchase a portion of CONMED’s outstanding 2.25% Convertible Senior Notes due 2026, and to pay fees and expenses\nincurred in connection with any such repurchase and the First Amendment.\n\n \n\nThe interest rate margins applicable to loans under\nthe Term A-2 Loan Facility shall be based on an adjusted term secured overnight financing rate (“SOFR”) plus a margin\nranging from 1.125% to 2.25% per annum, or a base rate plus a margin ranging from 0.125% to 1.25% per annum, in each case based on the\nconsolidated senior secured leverage ratio of CONMED. Prior to the first adjustment date to occur with respect to the fiscal quarter ending\nSeptember 30, 2026, the margins for loans under the Term A-2 Loan Facility will be 1.75% per annum for adjusted term SOFR borrowings,\nor 0.75% per annum for base rate borrowings.\n\n \n\nObligations in respect of the Term A-2 Loan Facility\nare secured by the same assets and rights of CONMED and certain of its subsidiaries that secure the other obligations under the Credit\nAgreement and related documents, and are guaranteed by the same subsidiaries of CONMED that guarantee the other obligations under the\nCredit Agreement and related documents.\n\n \n\nThe foregoing description of the First Amendment\ndoes not purport to be complete and is subject to, and qualified in its entirety by reference to, the complete text of the First Amendment,\na copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.\n\n \n\n 1"}